Wesley Center for Immunotherapy
Showing of 6 results
University Hospitals Seidman Cancer Center Launches Biotech Collaboration to Discover Cellular Immunotherapies for Head and Neck Cancer
Innovations in Ear, Nose & Throat | Winter 2023
Expansion of Wesley Center for Immunotherapy at University Hospitals Seidman Cancer Center Officially Opens
Addition brings more life-extending treatments and groundbreaking research to Northeast Ohio
New Hematology Chief and Director of the Wesley Center for Immunotherapy Named for UH Seidman Cancer Center
Koen van Besien, MD, PhD, comes to UH Seidman Cancer Center from New York-Presbyterian Hospital
New Immunotherapy Center at UH Seidman Cancer Center Sets the Stage for Solutions
Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021
More Specific Approach to CAR T Cell Therapy Shows Promise for B Cell Cancers
Investigational New Drug (IND) authorization is under way - Innovations in Cancer | Fall 2020
Wesley Family donates $10 million to University Hospitals Seidman Cancer Center
Gift establishes groundbreaking immunotherapy center - UH News Release
Results are loading...